The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Incyte Corp

Nasdaq: INCY
Last

(U.S.) $120.49

Today's change+0.31 +0.26%
Updated February 17 4:00 PM EST. Delayed by at least 15 minutes.
 

Incyte Corp

Nasdaq: INCY
Last

(U.S.) $120.49

Today's change+0.31 +0.26%
Updated February 17 4:00 PM EST. Delayed by at least 15 minutes.

Incyte Corp up (U.S.)$0.31

Incyte Corp closed up Friday by (U.S.)$0.31 or 0.26% to (U.S.)$120.49. Shares have lost 0.99% over the last five days, but sit 3.98% below their 52-week high. This security has outperformed the S&P 500 by 39.82% during the last year.

Key company metrics

  • Open(U.S.) $120.18
  • Previous close(U.S.) $120.18
  • High(U.S.) $120.85
  • Low(U.S.) $119.16
  • Bid / Ask(U.S.) $120.00 / (U.S.) $0.00
  • YTD % change+20.17%
  • Volume941,388
  • Average volume (10-day)1,308,006
  • Average volume (1-month)1,475,954
  • Average volume (3-month)1,394,256
  • 52-week range(U.S.) $60.30 to (U.S.) $125.49
  • Beta0.82
  • Trailing P/E223.76×
  • P/E 1 year forward183.20×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.54
Updated February 17 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.16%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue326269246263
Total other revenue--------
Total revenue326269246263
Gross profit307249234257
Total cost of revenue2020126
Total operating expense284247202227
Selling / general / administrative96766765
Research & development162143120157
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total782--
Operating income42224536
Interest income (expense), net non-operating-9-9-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax9383524
Income after tax9373424
Income tax, total1110
Net income9373424
Total adjustments to net income--------
Net income before extra. items9373424
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9373424
Inc. avail. to common incl. extra. items9373424
Diluted net income9373424
Dilution adjustment00--0
Diluted weighted average shares195194193193
Diluted EPS excluding extraordinary itemsvalue per share0.050.190.180.12
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.050.190.180.12